Synergistic protective effect of cyclosporin A and rotenone against hypoxia-reoxygenation in cardiomyocytes

J Mol Cell Cardiol. 2013 Mar:56:55-62. doi: 10.1016/j.yjmcc.2012.11.023. Epub 2012 Dec 10.

Abstract

Reperfusion of the heart after an ischemic event leads to the opening of a nonspecific pore in the inner mitochondrial membrane, the mitochondrial permeability transition pore (mPTP). Inhibition of mPTP opening is an effective strategy to prevent cardiomyocyte death. The matrix protein cyclophilin-D (CypD) is the best-known regulator of mPTP opening. In this study we confirmed that preconditioning and postconditioning with CypD inhibitor cyclosporin-A (CsA) reduced cell death after hypoxia-reoxygenation (H/R) in wild-type (WT) cardiomyocytes and HL-1 mouse cardiac cell line as measured by nuclear staining with propidium iodide. The complex I inhibitor rotenone (Rot), alone, had no effect on HL-1 and WT cardiomyocyte death after H/R, but enhanced the native protection of CypD-knocked-out (CypD KO) cardiomyocytes. Reduction of cell death was associated with a delay of mPTP opening challenged by H/R and observed by the calcein loading CoCl(2)-quenching technique. Simultaneous inhibition of complex I and CypD increased in a synergistic manner the calcium retention capacity in permeabilized cardiomyocytes and cardiac mitochondria. These results demonstrated that protection by complex I inhibition was CypD dependent.

MeSH terms

  • Animals
  • Cardiotonic Agents / pharmacology*
  • Cell Death
  • Cell Hypoxia / drug effects
  • Cells, Cultured
  • Cyclophilins / antagonists & inhibitors
  • Cyclophilins / genetics
  • Cyclophilins / metabolism
  • Cyclosporine / pharmacology*
  • Drug Synergism
  • Electron Transport Complex I / antagonists & inhibitors
  • Male
  • Mice
  • Mice, 129 Strain
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mitochondria, Heart / drug effects
  • Mitochondria, Heart / metabolism
  • Mitochondrial Membrane Transport Proteins / metabolism
  • Mitochondrial Permeability Transition Pore
  • Myocardial Reperfusion Injury / metabolism
  • Myocardial Reperfusion Injury / prevention & control
  • Myocytes, Cardiac / drug effects*
  • Myocytes, Cardiac / metabolism
  • Oxygen Consumption
  • Peptidyl-Prolyl Isomerase F
  • Permeability
  • Rotenone / pharmacology*

Substances

  • Cardiotonic Agents
  • Peptidyl-Prolyl Isomerase F
  • Mitochondrial Membrane Transport Proteins
  • Mitochondrial Permeability Transition Pore
  • PPIF protein, mouse
  • Rotenone
  • Cyclosporine
  • Cyclophilins
  • Electron Transport Complex I